Cargando…

Development and validation of analytical methods for selective determination of albuterol and budesonide in Airsupra inhalation aerosol using spectrophotometry

Airsupra inhalation aerosol is a recently approved FDA medication that combines albuterol and budesonide for treating or preventing bronchoconstriction and lowering the risk of relapses in asthma patients who are 18 years of age and older. To selectively determine albuterol and budesonide in both pu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Almalki, Atiah H., Ramzy, Sherif, Almrasy, Ahmed A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547681/ https://www.ncbi.nlm.nih.gov/pubmed/37789024 http://dx.doi.org/10.1038/s41598-023-42766-y

Ejemplares similares

Subcutaneous terbutaline as an alternative to aerosolized albuterol
por: Strauss, Ronald A.
Publicado: (2020)

Bronchoscopy for foreign body aspiration and effects of nebulized albuterol and budesonide combination
por: Akcora, Bulent, et al.
Publicado: (2017)

Reply to “Subcutaneous terbutaline as an alternative to aerosolized albuterol”
por: Shaker, Marcus S., et al.
Publicado: (2020)

The Effects of Inhaled Albuterol in Transient Tachypnea of the Newborn
por: Kim, Myo-Jing, et al.
Publicado: (2014)

Long-term maintenance of pediatric asthma: focus on budesonide/formoterol inhalation aerosol
por: Huynh, Peter N, et al.
Publicado: (2010)

Effect of inhaled albuterol on whole blood potassium concentrations in dogs
por: Ogrodny, Andrzej, et al.
Publicado: (2022)

Use of aerosol inhalation treatment with budesonide and terbutaline sulfate on acute pediatric asthmatic bronchitis
por: Bian, Fangfang, et al.
Publicado: (2017)

Correlation between the vitamin D levels and asthma attacks in children: Evaluation of the effects of combination therapy of atomization inhalation of budesonide, albuterol and vitamin D supplementation on asthmatic patients
por: Kang, Qinhong, et al.
Publicado: (2018)

Repeated use of albuterol inhaler as a potential cause of Takotsubo cardiomyopathy
por: Patel, Brijesh, et al.
Publicado: (2014)

Efficacy of Inhaled Levalbuterol Compared to Albuterol in Horses with Recurrent Airway Obstruction
por: Arroyo, M.G., et al.
Publicado: (2016)

Response to first dose of inhaled albuterol in mechanically ventilated preterm infants
por: Raffay, Thomas M., et al.
Publicado: (2021)

Efficacy and safety of as-needed albuterol/budesonide versus albuterol in adults and children aged ≥4 years with moderate-to-severe asthma: rationale and design of the randomised, double-blind, active-controlled MANDALA study
por: Chipps, Bradley E, et al.
Publicado: (2021)

Higher sensitive selective spectrofluorometric determination of ritonavir in the presence of nirmatrelvir: application to new FDA approved co-packaged COVID-19 pharmaceutical dosage and spiked human plasma
por: Imam, Mohamed S., et al.
Publicado: (2023)

Comparison of HPMC Inhalation-Grade Capsules and Their Effect on Aerosol Performance Using Budesonide and Rifampicin DPI Formulations
por: Ding, Li, et al.
Publicado: (2022)

Real-world health care utilization in asthma patients using albuterol sulfate inhalation aerosol (ProAir(®) HFA) with and without integrated dose counters
por: Kerwin, Edward M, et al.
Publicado: (2017)

Green fitted second derivative synchronous spectrofluorometric method for simultaneous determination of remdesivir and apixaban at Nano gram scale in the spiked human plasma
por: Batubara, Afnan S., et al.
Publicado: (2023)

Comparison of Aerosol Formulations of Formoterol Fumarate and Budesonide
por: Nirale, N. M., et al.
Publicado: (2011)

Green-adapted spectrophotometric determination of fostemsavir based on selective bromophenol blue extraction; reduction of hazardous consumption using computational calculations
por: Batubara, Afnan S., et al.
Publicado: (2023)

Recent Analytical Advances for Decoding Metabolic Reprogramming in Lung Cancer
por: Almalki, Atiah H.
Publicado: (2023)

Adjusted green HPLC determination of nirmatrelvir and ritonavir in the new FDA approved co-packaged pharmaceutical dosage using supported computational calculations
por: Imam, Mohamed S., et al.
Publicado: (2023)

Budesonide–formoterol (inhalation powder) in the treatment of COPD
por: Ceylan, Erkan
Publicado: (2006)

Inhaled budesonide for early treatment of COVID-19
por: Choi, Jae Chol, et al.
Publicado: (2021)

Inhaled budesonide for early treatment of COVID-19
por: San-Juan, Rafael, et al.
Publicado: (2021)

Inhaled budesonide for early treatment of COVID-19
por: Zeitlinger, Markus, et al.
Publicado: (2021)

Twelve- and 52-week safety of albuterol multidose dry powder inhaler in patients with persistent asthma
por: Raphael, Gordon, et al.
Publicado: (2016)

Determination of albuterol and montelukast post-expiry drug strength by HPLC
por: Kutty, Raman G., et al.
Publicado: (2022)

Green adherent spectrophotometric determination of molnupiravir based on computational calculations; application to a recently FDA-approved pharmaceutical dosage form
por: Abdelazim, Ahmed H., et al.
Publicado: (2023)

Efficiency of Ipratropium Bromide and Albuterol Deposition in the Lung Delivered via a Soft Mist Inhaler or Chlorofluorocarbon Metered‐Dose Inhaler
por: MacGregor, TR, et al.
Publicado: (2016)

Determination and Validation of Zonisamide and its Four Related Substances by HPLC and UV-Spectrophotometry
por: Hosseini, Maryam, et al.
Publicado: (2010)

Esophageal Crohn's Disease Treated “Topically” with Swallowed Aerosolized Budesonide
por: Zezos, Petros, et al.
Publicado: (2010)

Efficacy of inhaled budesonide for the treatment of severe equine asthma
por: Lavoie, J. P., et al.
Publicado: (2018)

Inhalatives Budesonid zur Therapie bei COVID-19
por: Kluge, S., et al.
Publicado: (2021)

Comparison of Nebulized Epinephrine to Albuterol in Bronchiolitis
por: Walsh, Paul, et al.
Publicado: (2008)

Significant Lactic Acidosis from Albuterol
por: Hockstein, Maxwell, et al.
Publicado: (2018)

Efficacy and safety of eco-friendly inhalers: focus on combination ipratropium bromide and albuterol in chronic obstructive pulmonary disease
por: Panos, Ralph J
Publicado: (2013)

Quantitative analysis of two COVID-19 antiviral agents, favipiravir and remdesivir, in spiked human plasma using spectrophotometric methods; greenness evaluation
por: Batubara, Afnan S., et al.
Publicado: (2023)

Guava-fruit based synthesis of carbon quantum dots for spectrofluorometric quantitative analysis of risperidone in spiked human plasma and pharmaceutical dosage forms
por: Alaqel, Saleh I., et al.
Publicado: (2023)

Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review
por: Dyer, Matthew J, et al.
Publicado: (2006)

Inhaled budesonide for early treatment of COVID-19 – Authors' reply
por: Ramakrishnan, Sanjay, et al.
Publicado: (2021)

Efficacy and safety of ipratropium bromide/albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trial
por: Donohue, James F., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mgsao5pt69vc4rjebo8bomml8q